Advancing Healthcare in China: Removing Legal Constraints on Drug and Device Approvals

Thursday, November 7, 2019
Furman Hall, Room 318
245 Sullivan Street
New York, New York, 10012
12:15 - 1:50 PM

RSVP*

*RSVP Required for NYU Access & Catering

About the Event

Balzano will describe how China has moved to significantly reduce drug and medical device regulation in order to encourage innovation. Please note: recording devices are not allowed.

About the Speaker

John Balzano is partner at Covington & Burling LLP and represents companies and business associations on U.S. and China regulatory and policy matters related to food, drugs, medical devices, cosmetics, and other regulated products. Mr. Balzano has over a decade of experience with legal and regulatory issues related to China, particularly with regard to products regulated by the State Administration for Market Regulation, the National Medical Products Administration (NMPA), and other agriculture, animal and healthcare (including digital health) products and services. He assists clients with developing strategies to obtain pre-market approvals for these products in China, including clinical development, understanding relevant pricing and reimbursement policies, and reviewing distribution and promotional plans.